-
公开(公告)号:US20220016257A1
公开(公告)日:2022-01-20
申请号:US17293577
申请日:2019-11-13
发明人: Atsuko SAITO , Naoya HARADA , Kozo YONEDA , Ichiro HAYAKAWA , Masaki MEGURO , Fuminao DOI
摘要: An object of the present invention is to provide an antibody specifically binding to CDH6 and having a high internalization activity, an antibody-drug conjugate comprising the antibody and a high antitumor activity, a pharmaceutical product having the antibody-drug conjugate and having a therapeutic effect on a tumor, a method for treating a tumor using the antibody, the antibody-drug conjugate or the pharmaceutical product, and the like.
According to the present invention, it is possible to provide an anti-CDH6 antibody prepared having internalization activity, an anti-CDH6 antibody-drug conjugate prepared by connecting the anti-CDH6 antibody and a novel PBD derivative and exhibiting high anti-tumor activity, a pharmaceutical product and a therapeutic method for treating tumors using these.-
公开(公告)号:US20230084707A1
公开(公告)日:2023-03-16
申请号:US17714032
申请日:2022-04-05
发明人: Narihiro TODA , Yusuke OTA , Fuminao DOI , Masaki MEGURO , Ichiro HAYAKAWA , Shinji ASHIDA , Takeshi MASUDA , Takashi NAKADA , Mitsuhiro IWAMOTO , Naoya HARADA , Tomoko TERAUCHI , Daisuke OKAJIMA , Kensuke NAKAMURA , Hiroaki UCHIDA , Hirofumi HAMADA
IPC分类号: A61K47/68 , A61P35/00 , C07K16/30 , C07D487/04
摘要: The present invention provides a novel antibody-pyrrolodiazepine derivative and a novel antibody-pyrrolodiazepine derivative conjugate using the same, and a novel CLDN6 and/or CLDN9 antibody.
-
公开(公告)号:US20220125943A1
公开(公告)日:2022-04-28
申请号:US17543697
申请日:2021-12-06
发明人: Narihiro TODA , Yusuke OTA , Fuminao DOI , Masaki MEGURO , Ichiro HAYAKAWA , Shinji ASHIDA , Takeshi MASUDA , Takashi NAKADA , Mitsuhiro IWAMOTO , Naoya HARADA , Tomoko TERAUCHI , Daisuke OKAJIMA , Kensuke NAKAMURA , Hiroaki UCHIDA , Hirofumi HAMADA
IPC分类号: A61K47/68 , A61P35/00 , C07D487/04 , C07K16/30
摘要: The present invention provides a novel antibody-pyrrolodiazepine derivative and a novel antibody-pyrrolodiazepine derivative conjugate using the same, and a novel CLDN6 and/or CLDN9 antibody.
-
公开(公告)号:US20220168440A1
公开(公告)日:2022-06-02
申请号:US17442605
申请日:2020-03-24
发明人: Narihiro TODA , Yusuke OTA , Fuminao DOI , Masaki MEGURO , Ichiro HAYAKAWA , Shinji ASHIDA , Takeshi MASUDA , Takashi NAKADA
IPC分类号: A61K47/68 , C07D519/00 , A61P35/00
摘要: A novel antibody-pyrrolobenzodiazepine (PBD) derivative conjugate, a medicine having therapeutic effect against tumor with the antibody-drug conjugate, and a method for treating a tumor by using the antibody-drug conjugate or medicine.
-
公开(公告)号:US20220395579A1
公开(公告)日:2022-12-15
申请号:US17849688
申请日:2022-06-26
发明人: Narihiro TODA , Yusuke OTA , Fuminao DOI , Masaki MEGURO , Ichiro HAYAKAWA , Shinji ASHIDA , Takeshi MASUDA , Takashi NAKADA , Mitsuhiro IWAMOTO , Naoya HARADA , Tomoko TERAUCHI , Daisuke OKAJIMA , Kensuke NAKAMURA , Hiroaki UCHIDA , Hirofumi HAMADA
IPC分类号: A61K47/68 , A61P35/00 , C07D487/04 , C07K16/30
摘要: The present invention provides a novel antibody-pyrrolodiazepine derivative and a novel antibody-pyrrolodiazepine derivative conjugate using the same, and a novel CLDN6 and/or CLDN9 antibody.
-
公开(公告)号:US20200261594A1
公开(公告)日:2020-08-20
申请号:US16651501
申请日:2018-09-28
发明人: Narihiro TODA , Yusuke OTA , Fuminao DOI , Masaki MEGURO , Ichiro HAYAKAWA , Shinji ASHIDA , Takeshi MASUDA , Takashi NAKADA , Mitsuhiro IWAMOTO , Naoya HARADA , Tomoko TERAUCHI , Daisuke OKAJIMA , Kensuke NAKAMURA , Hiroaki UCHIDA , Hirofumi HAMADA
IPC分类号: A61K47/68 , C07D487/04 , C07K16/30 , A61P35/00
摘要: The present invention provides a novel antibody-pyrrolodiazepine derivative and a novel antibody-pyrrolodiazepine derivative conjugate using the same, and a novel CLDN6 and/or CLDN9 antibody.
-
公开(公告)号:US20140343052A1
公开(公告)日:2014-11-20
申请号:US14291860
申请日:2014-05-30
发明人: Shigeo YAMANOI , Katsuji KAGECHIKA , Tsuyoshi SONEDA , Yuichi OCHIAI , Hidenori NAMIKI , Fuminao DOI , Madoka HOSHINO , Shoko YOSHIDA
IPC分类号: C07D405/10 , C07D413/14 , C07D405/14
CPC分类号: C07D405/10 , C07D405/14 , C07D413/14
摘要: The present invention relates to a compound or a pharmacologically acceptable salt thereof having an excellent glucose lowering effect.A compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof: wherein R1 represents a C1-C3 alkyl group, each substituent R2 may be the same or different and may each represent a C1-C3 alkyl group, R3 represents an optionally substituted pyridyl group or the like, R4 and R5, which are the same or different, each represent a C1-C3 alkyl group, R6 and R7, which are the same or different, each represent a C1-C3 alkyl group, and n represents 0 to 3.
摘要翻译: 本发明涉及具有优异葡萄糖降低作用的化合物或其药理学上可接受的盐。 由以下通式(I)表示的化合物或其药学上可接受的盐:其中R1表示C1-C3烷基,各取代基R2可以相同或不同,可各自表示C1-C3烷基,R3表示 任选取代的吡啶基等,R 4和R 5相同或不同,各自表示C1-C3烷基,R6和R7相同或不同,分别表示C1-C3烷基,和 n表示0〜3。
-
-
-
-
-
-